Literature DB >> 19817632

Interrater reliability for Kernberg's structural interview for assessing personality organization.

Theo J M Ingenhoven1, Hugo J Duivenvoorden, Janneke Brogtrop, Anne Lindenborn, Wim van den Brink, Jan Passchier.   

Abstract

Interrater reliability is considered a precondition for the validity of theoretical models and their corresponding diagnostic instruments. Studies have documented good interrater reliability for structured interviews measuring personality characteristics on a descriptive-phenomenological level but there is little research on reliability of assessment procedures on a structural level. The current study investigated the interrater reliability of the structural interview (SI) designed to assess neurotic, borderline, and psychotic personality organization according to Kernberg. Videotaped SIs of 69 psychiatric patients were randomly and independently rated by two out of three trained psychologists. Agreement between rater pairs was expressed as square weighted kappa (K(sw), 95% CI). Results indicate satisfactory interrater reliability with respect to Kernberg's tripartite classification (K(sw) = 0.42, 95% CI 0.07 to 0.77). Subdivision of the borderline category or introduction of intermediate subcategories to the tripartite system did not significantly affect reliability (K(sw) = 0.55, 95% CI 0.30 to 0.80; K(sw) = 0.59, 95% CI 0.34 to 0.84, respectively). The conclusion is that trained clinicians can reliably assess structural personality organization using the SI. Refining the nosological system adding subcategories did not reduce reliability.

Entities:  

Mesh:

Year:  2009        PMID: 19817632     DOI: 10.1521/pedi.2009.23.5.528

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  1 in total

1.  A comparison of Cohen's Kappa and Gwet's AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples.

Authors:  Nahathai Wongpakaran; Tinakon Wongpakaran; Danny Wedding; Kilem L Gwet
Journal:  BMC Med Res Methodol       Date:  2013-04-29       Impact factor: 4.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.